- Study at Deakin
- Campus life
- Industry and community
- About Deakin
This interactive workshop will equip current Clinical Nurse Educators, facilitators,preceptors
and nurses interested in clinical education with theskills and knowledge required to facilitate effective learning in nursing students. Utilising principles of
adult and self-directed learning, participants will learn strategies to motivate students, encourage
independent learning, provide targeted feedback and assess students consistent with the ANMC
Morning tea and lunch included.
Deakin sessional staff member or current clinical facilitators/preceptors: Free of Charge
Employed within a Deakin Partnership Health Care Service: $80.00
All other registrations: $120.00
Deakin University researchers, as well as members of the local Geelong community, have played a key role in developing a novel approach for detecting coeliac disease.
More than 2500 men and women enrolled in the Geelong Osteoporosis Study provided blood samples for traditional antibody testing and identification of specific genetic risk markers.
‘The randomly-selected participants in the Geelong Osteoporosis Study are ideal for this project because they represent the broader population and were not selected on the basis of disease’, said lead investigator and epidemiologist, Professor Julie Pasco from Deakin University’s School of Medicine.
Coeliac disease is a digestive condition caused by eating gluten in foods made from wheat, barley, rye and oats and can be found in people of any age.
The Geelong-based research team involved endocrinologist Associate Professor Mark Kotowicz and gastroenterologist Dr Ross Knight. Other key players included Dr Jason Tye-Din from the Immunology division of the Walter and Eliza Hall Institute, Dr Bob Anderson, chief scientific officer at US biotechnology company ImmusanT and researchers from The University of Queensland Diamantina Institute.
Dr Tye-Din said the new approach of combining the genetic test with a panel of antibody tests would increase the accuracy of testing, decrease overall medical costs by reducing invasive diagnostic tests, and avoid medically unnecessary use of a gluten-free diet.
‘Currently, bowel biopsies are recommended for anybody with positive antibody tests’, he said.
‘In this study the inclusion of a genetic test helped identify a substantial number of people whose antibody tests were falsely positive and who did not actually require a bowel biopsy to test for the possibility of coeliac disease.’
The new testing strategy reveals that coeliac disease is more common in Australia than previously thought, affecting at least one in 60 women and one in 80 men.
The research was funded by INOVA Diagnostics Inc, Nexpep Pty. Ltd, the NHMRC, the Victorian Health Promotion Foundation, the Geelong Region Medical Research Foundation, and the Victorian government.
Do you have depression and are looking for something more
than your usual treatment?
This exciting new study will look at the benefits of adding a new treatment for depression to your usual treatment.
For more information, click on the link below or contact:
Dr Olivia Dean
Telephone (03) 4215 3300